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 The hospital anxiety and depression scale depression subscale, but not the 
Beck depression inventory – fast scale, identifies acute coronary syndrome 
patients at elevated risk of one-year mortality 
 
Brief depression scale predicts mortality in ACS 
 
 
 
Objective: To investigate the use of short-form depression scales in assessing 
one-year mortality risk in a national sample of acute coronary syndrome (ACS) 
patients. 
Methods: ACS patients (N=598) completed either a Hospital Anxiety and 
Depression Scale depression subscale (HADS-D) or the Beck Depression 
Inventory - Fast Scale (BDI-FS). Mortality status was assessed at one-year. 
Results: Cox proportional hazards modelling showed that patients depressed at 
baseline (combining HADS-D and BDI-FS depressed cases) were more likely to 
die within one year (HR 2.8, 95% CI 1.4 to 5.7, p=0.005), even when controlling 
for major medical and demographic variables (HR 4.1, 95% CI 1.6 to 10.3, 
p=0.003). Scoring above threshold on the HADS-D predicted mortality (HR 4.2, 
95% CI 1.8 to 10.0, p=0.001), but scoring above threshold on the BDI-FS did not 
(HR 1.8, 95% CI 0.6 to 5.6, p=0.291). 
Conclusion: The HADS-D predicted increased risk of one-year mortality in ACS 
patients.  
Introduction 
 
Acute coronary syndromes (ACS) are an important mode of cardiovascular 
diseases, and include unstable angina and acute myocardial infarction (AMI) [1]. 
Morbidity and mortality post-AMI are determined by a number of independent risk 
factors, including extent of coronary artery disease, infarct size, severity of left 
ventricular dysfunction, and depression [2-6]. Depression following ACS has 
been found to be an important risk factor for further coronary events, with even 
low levels of depression having a significant effect on mortality risk [7-9]. A recent 
meta-analysis has concluded that post-AMI depression is associated with a 2- to 
2.5-fold increased risk of impaired cardiovascular outcome [10]. Similar findings 
have been found for patients with all types of coronary artery disease [11,12]. 
 
The identification of depression in ACS patients is therefore a concern for 
clinicians. Early diagnosis and active management of depression may improve 
cardiac morbidity and mortality [13]. A recent review found that between 8 to 45% 
of patients who have suffered an AMI exhibit symptoms of major depression [5]. 
The mechanisms by which depression increases risk of post-AMI mortality are 
not fully understood. It is feasible that some of the negative association between 
depression and outcome reflects poorer cardiac function post-event. 
Alternatively, depression may have a causal association with worse outcomes. 
Physiological explanations have been proposed, including increased sympathetic 
activity, arterial atherosclerosis, and heart rate variability [14]. One important 
psychosocial factor is that depressed patients are less likely to adhere to 
recommendations for secondary prevention [15,16]. A recent meta-analysis 
across a range of medical conditions showed that non-adherence to medical 
treatment is three times more likely to occur with depressed than non-depressed 
patients [17]. 
 
Assessment methods for depression have traditionally involved either clinical 
interviews conducted by experienced mental health professionals or lengthy self-
completion questionnaires [3,18]. These preclude routine assessment of 
depression in most cardiac settings. If evidence showing the effects of 
depression on mortality is to translate into information useful for the care of 
individual patients, depression assessment needs to become a routine aspect of 
coronary care. Brief screening instruments for depression exist but have not 
been tested for their sensitivity and predictive validity in the cardiac setting. The 
present study assessed the feasibility of using short-form depression scales in an 
acute setting to ascertain the impact of self-assessed depression on one-year 
mortality post-ACS. Two short-form scales were assessed: the Hospital Anxiety 
and Depression Scales depression subscale (HADS-D) [19] and the Beck 
Depression Inventory - Fast Scale (BDI-FS) [20]. 
 
 
Method 
Sample/Participants 
 
Hospitals 
The methodology has been described in detail elsewhere [21]. Briefly, all Irish 
centres admitting patients with suspected ACS to intensive/coronary care units 
were invited and agreed to participate in a general ACS survey. Hospitals were 
randomly assigned to distribute the either HADS-D (n=19) or the BDI-FS (n=19) 
instruments (one hospital did not participate in the depression assessment 
aspect of the survey). Ethics committee approval was obtained from individual 
centres/areas as appropriate [22]. 
 
Participants/procedure 
Hospitals recruited consecutive suspected ACS patients, until 25 suspected 
cases of AMI were admitted. Where considered appropriate by staff, patients 
were invited to participate in the depression assessment and in a one-year 
follow-up survey (results to be reported elsewhere). Patients thus completed the 
depression scales 2-5 days after admission. To participate, patients provided 
written informed consent, and completed either a HADS-D (n=316) or BDI-FS 
(n=282). This paper analyses data from patients discharged with confirmed ACS, 
who completed a depression scale, and whose mortality was assessed at one-
year (Fig 1). Demographic and clinical data were collected. Primary care 
physicians were contacted one year later to ascertain patients’ vital status, and 
date of death was obtained from a national births, marriages and deaths registry.  
 
--------------------------- 
Fig 1 about here 
--------------------------- 
 
 
Depression measures 
 
The 14-item HADS consists of two 7-item scales for depression (HADS-D) and 
anxiety (HADS-A) [19]. Each item has a four-answer option format. Scores range 
from 3 for most severe to 0 for absence of problem in that area. The HADS was 
developed to identify psychological disturbances in general medical and non-
psychiatric samples. Using the optimal cut-off score of >7, the HADS-D can 
indicate probable cases of depression with an average sensitivity and specificity 
of approximately 0.80 [23]. This threshold (>7) was used in the current study for 
the HADS-D. 
 
The 7-item BDI-FS is a shortened version of the BDI [24], and the two versions 
are highly correlated with high internal reliability [25]. The BDI-FS is a screening 
instrument that minimises the possibility of yielding spuriously high estimates of 
depression for patients with medical problems by focusing on cognitive (as 
distinct from physical/somatic) symptoms of depression. Each item has a four-
answer option format. Scores range from 3 for most severe to 0 for absence of 
problem in that area. A BDI-FS cut-off score of >3 yields a sensitivity and 
specificity of 0.82 for detecting major depressive disorders [26]. This threshold 
(>3) was used in the current study. 
 
Both scales are designed not to be contaminated by clinical factors, as they 
focus on cognitive aspects of depression. Both can be easily completed within 
five minutes. 
 
 
Statistical analysis 
 
Data were analysed using robust variance estimation methods with STATA/SE 
8.2 to account for the clustering of patients within hospitals. This method was 
used as patients in the same hospital will be more similar than patients randomly 
sampled from the entire population, leading to under-estimation of standard 
errors and confidence intervals and a greater than 5% rate of false positive (type 
I) errors. Robust variance estimation adjusted standard errors (and therefore 
confidence intervals and significance tests) for the homogeneity introduced by 
cluster sampling. Differences between the HADS-D and BDI-FS samples were 
assessed using the χ2 test or t-tests as appropriate. Logistic regression predicted 
odds-ratios (OR) for event occurrence. Cox proportional hazards regression 
predicted hazard ratios (HR) for one-year mortality. Personal and medical 
variables were analysed as univariate predictors of mortality (having private 
health insurance was used as a proxy for socioeconomic status, length of 
hospital stay after admission to coronary care was used as a proxy for severity of 
ACS) and predictors were combined to determine the overall HR for depression. 
One-year mortality for the HADS-D and BDI-FS samples were calculated 
independently, but due to sample size, only age and sex were used as covariates 
when analysing the HADS-D and BDI-FS samples separately. To combine data 
for the overall sample, patients scoring above threshold on either the HADS or 
BDI-FS were defined as depressed. In order to compare depression scales, 
dummy variables were created for the total sample (i.e. scoring above cut-off for 
BDI-FS or not – all participants who completed a HADS-D were given a score of 
zero in this variable; and vice versa). Both dummy variables were incorporated 
into a model predicting mortality. A post-hoc (Wald) test determined whether one 
scale was superior to the other for mortality prediction. 
 
 
Results 
 
Baseline characteristics 
 
There were no differences between the groups on baseline characteristics other 
than cholesterol (Table 1). Patients who completed the HADS-D had a lower total 
cholesterol level than those who completed the BDI-FS (t=2.47, p= 0.014). 
  
Response rates 
 
Staff did not offer (according to institutional assignment) the HADS-D to 2 (0.5%) 
patients, and the BDI-FS was not offered to 7 (1.6%) patients (OR 0.3, 95% CI 
0.1 to 1.6, p=0.152). Overall, 598 (73%) completed a scale. The response rate 
between scales did not differ, with 316 (78%) completing the HADS-D and 282 
(67%) completing the BDI-FS (OR 1.6, 95% CI 0.9 to 2.9, p=0.118). Non-
responders were older (OR 1.02, 95% CI 1.0 to 1.03, p=0.017) and more likely to 
have diabetes (OR 1.6, 95% CI 1.0 to 2.3, p=0.035), when controlling for sex and 
private health insurance. 
 
 
Baseline depression 
 
Fewer patients who completed the HADS-D were found to be depressed, with 47 
(15%) patients shown to be depressed, whereas 62 (22%) of those who 
completed the BDI-FS were depressed (OR 0.6, 95% CI 0.4-1.0, p=0.035). 
Overall 109 (18%) patients were depressed. 
 
 
Mortality 
 
Mortality rates for the two groups did not differ (OR 0.9, 95% CI 0.4 to 1.9, 
p=0.758), with 12 (4%) of those who completed either scale confirmed as 
deceased after one-year (Fig 1). Patients who did not complete either scale had 
a higher one-year mortality rate, with 30 (13%) patients deceased (OR 3.5, 95% 
CI 2.0-6.2, p<0.001). 
 
Significant univariate predictors of mortality (Table 2) were age, sex, private 
health insurance, prior diabetes, prior unstable angina, total cholesterol level, 
length of hospital stay (after intensive/coronary care admission) and depression. 
Prior ACS (overall), hypertension, reperfusion during admission and having 
smoked (ever smoker) were not significant predictors of mortality. The Kaplan-
Meier survival curve for depressed and non-depressed patients is shown in figure 
2 (a). 
 
Depression predicted mortality in multiple Cox regression when controlling for 
age and sex (HR 3.0, 95% CI 1.5 to 6.1, p=0.002), and when including other 
univariate predictors with a p-value <0.15 (see Table 2) (HR 4.1, 95% CI 1.6 to 
10.3, p=0.003). 
 
--------------------------- 
Fig 2 about here 
--------------------------- 
 
 Scale comparison 
 
Scoring above threshold on the HADS-D predicted mortality (HR 4.2, 95% CI 1.8 
to 10.0, p=0.001), even when controlling for age and sex (HR 4.0, 95% CI 1.7 to 
9.1, p=0.001). Raw scores also predicted mortality, with a 19% increase in risk 
per unit increase on HADS-D score (HR=1.2, 95% CI 1.1 to 1.4, p=0.008). 
 
Scoring above threshold on the BDI-FS did not significantly predict mortality (HR 
1.8, 95% CI 0.6 to 5.6, p=0.291), even when controlling for age and sex (HR 2.3, 
95% CI 0.7 to 7.4, p=0.156).  BDI-FS raw scores did not predict mortality (HR 
1.1, 95% CI 0.9 to 1.4, p=0.38). Figure 2 shows survival curves for patients who 
completed (b) the HADS-D, and (c) the BDI-FS. 
 
The data were then analysed for the total sample, using dummy variables and 
incorporating the data for the HADS-D and BDI-FS samples separately. A Wald 
post-hoc test revealed no significant difference between the HADS-D and the 
BDI-FS for risk prediction (χ2=0.82, p=0.365). 
 
 
Discussion 
The present study evaluated the use of short-form depression questionnaires in 
an acute cardiac setting, comparing the HADS-D with the BDI-FS. Factors which 
increase risk post-event were similar in the two groups, with two exceptions. 
Serum total cholesterol was lower in the HADS-D group, and the HADS-D found 
a lower prevalence of baseline depression. 
 
The response rates showed that the scales were generally acceptable to patients 
in acute settings, with older patients and those with diabetes less likely to 
complete the scales. There was therefore an expected higher mortality rate in 
those patients who did not complete a depression scale. Also, staff distributed 
the questionnaires to virtually all (99%) of patients in the current sample, 
indicating high staff acceptance. The findings of this study show a substantial 
level of depression (18%) in post-ACS patients, in line with previous research 
with cardiac patients [3,15]. 
 
Combined depression scores predicted mortality, even when controlling for other 
risk factors (including a proxy for disease severity). Depression, as measured by 
the HADS-D, but not the BDI-FS, predicted one-year mortality in ACS patients. 
One reason for this may relate to the aspect of depression each scale measures. 
The HADS-D concentrates on anhedonia (the inability to experience pleasure), 
whereas the BDI-FS focuses on psychiatric criteria for major depressive disorder. 
Anhedonia may therefore be an important aspect of depression in relation to 
cardiac mortality. The BDI-FS found a higher prevalence of depression, and this 
may indicate a higher sensitivity for depression detection than the HADS-D. 
Using more stringent criteria for the BDI-FS depression threshold had no 
significant impact on results (data not shown). Therefore we recommend the 
HADS-D for rapid screening of depression and mortality risk prediction in ACS 
patients. One caveat to note is that although the HADS-D predicted mortality, a 
post-hoc analysis showed that it was not significantly different to the BDI-FS. 
Therefore, the BDI-FS was predicting some elevated risk, but not significantly 
different to chance. The HADS-D predicted mortality greater than chance. 
Although the HADS-D performed better for risk prediction in the present survey, it 
cannot be concluded that the BDI-FS is of no use in risk prediction. Previous 
studies which used the HADS have had conflicting results. Herrmann and 
colleagues showed that the HADS-D was associated with higher mortality in 
multivariate analysis in cardiology patients referred for exercise testing [27]. 
Mayou et al found that AMI patients with elevated HADS scores did not show 
higher risk of mortality [13], however these researchers used a composite of both 
anxiety and depression scales, and this may explain these negative findings. 
 
Other researchers have suggested that the predictive value of depression is 
simply a measurement of underlying cardiac disease that is not currently picked 
up by conventional risk factors – i.e. it is not depressive disorder per se [28]. 
Indeed, one recent systematic review showed inconclusive results due to 
methodological issues [29]. Further research reviewed 10 studies reporting at 
least 30 fatal events, and showed that in 8 out of 10 of these studies there was 
no statistically significant relationship between depression and mortality after 
adjustment for potential confounders [30]. There are other explanations for these 
conflicting results. It may be that the time of depression assessment post-event 
determines whether depression predicts outcomes. Measurement in hospital may 
be more predictive of mortality (and it may thus be a proxy measurement of 
severity of cardiac disease [31]). A further explanation may be that the instrument 
used determines whether outcomes are predicted by ‘depression’. The present 
study supports this conclusion. Also supportive of this is previous research that 
reported an increased mortality risk for the (full version) BDI scale when 
compared to an interview for DSM-IIIR criteria (OR=3.64 for interview vs. 
OR=7.82 for BDI) [4]. These authors also noted that the diagnostic interview did 
not significantly improve the predictive ability of a model predicting mortality, but 
the BDI did. Recent research using the BDI has shown that somatic/affective 
symptoms of post-AMI depression are confounded by somatic health status, 
whereas cognitive/affective symptoms of depression were not related to cardiac 
prognosis, and only marginally related to health status [32]. The full-length BDI 
could therefore be confounded by somatic items when predicting mortality in 
cardiac patients. Further research should be aware of possible confounding. 
Studies could concentrate on different theoretical aspects of depression (e.g. 
reduction in pleasurable activities), and whether these impact on depression and 
subsequent morbidity and mortality in cardiac patients. This could determine 
whether it is actual ‘psychological’ depression that is predictive of outcomes. 
 
Previous studies of depression in this area have typically involved assessment of 
patients using clinical interviews and lengthy patient-completion questionnaires 
[3,8,18]. This approach is not feasible in most centres. One study which used 
interview assessment for depression within a comparable timeframe (i.e. 2-5 
days after admission) achieved a 40.9% response rate [8]. Our 73% response 
rate compares favourably to this figure. Short instruments are useful for drawing 
attention to possible mood disturbance in an environment where this would not 
be routinely assessed. Although the instruments assessed here are screening 
rather than diagnostic tools, our results show the HADS-D is an acceptable 
substitute for identifying patients at high-risk for post-ACS mortality, and 
therefore provides clinically useful information. 
 
The treatment of depression in ACS patients has been shown to reduce 
depression and increase quality of life, but it has not to date reduced subsequent 
mortality [33]. Aside from mortality and quality of life related issues, depressed 
AMI patients have been found to place a greater demand on healthcare 
resources [34]. Identification and treatment of this group is advisable, both for 
service providers and patients. The prevalence of depression argues for a strong 
role for liaison psychiatry in helping to optimise quality of life in coronary disease 
patients. The challenge to psychiatry is to optimise quality of life by developing 
strategies for detecting and managing those at increased risk. The initial use of 
short-form questionnaires, such as the HADS-D, may have a role in the initial 
identification of these patients. 
 
The findings of this study are limited to patients who completed a depression 
questionnaire at baseline and who did not decline follow-up. Indeed, higher 
mortality was seen in those patients who did not complete a scale at baseline. It 
is possible that severely ill (and/or more depressed) patients were not included at 
baseline. Analysis did account for standard cardiovascular risk factors, in an 
effort to prevent confounding. However, some standard clinical factors (prior 
ACS), did not predict mortality. 
 
Conclusions 
 
Depression can be measured in a brief but clinically meaningful way in acute 
settings. A 7-item depression screening scale, the HADS-D, predicted one-year 
mortality in ACS patients; another scale, the BDI-FS, did not. This study adds to 
the evidence in support of systematic screening for depression after an acute 
cardiac event.  
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Table 1: Baseline characteristics of sample, n (%) unless otherwise stated 
 
 
Completed 
HADS-D 
Completed 
BDI-FS 
P-value 
Demographics    
Age (years) (mean) (std dev) 63 (13) 62 (12) 0.331 
   Men 235 (74) 221 (78) 0.343 
   Health insurance (private) 116 (37) 101 (37) 0.963 
Previous risk factor history    
Prior diabetes 37 (12) 35 (12) 0.826 
Total cholesterol (mmol/l) (mean) (std dev) 4.9 (1.2) 5.1 (1.1) 0.014* 
Ever smoker 241 (77) 215 (78) 0.949 
Prior ACS 112 (35) 111 (37) 0.440 
   Myocardial infarction 60 (19) 59 (20) 0.509 
   Unstable angina 57 (18) 53 (18) 0.849 
Prior revascularisation 47 (15) 56 (19) 0.165 
Prior hypertension 132 (41) 115 (41) 0.832 
Reperfusion received 109 (34) 89 (32) 0.533 
Length of hospital stay (median) (inter-quartile range) 9 (5-13) 8 (6-13) 0.159 
*p<0.05 
 
Table 2: Univariate Cox regression predictors of mortality for total sample 
 
 HR 95% P-value 
Age 1.08 1.04 to 1.1 <0.001‡ 
Sex 0.4 0.1 to 0.9 0.029* 
Health insurance (private) 0.2 0.08 to 0.7 0.007† 
Previous risk factor history    
Prior diabetes 4.9 2.1 to 11.2 <0.001‡ 
Total cholesterol (mmol/l) (mean) 0.5 0.3 to 0.8 0.003† 
Ever smoker 0.5 0.2 to 1.1 0.1 
Prior ACS 1.7 0.7 to 4.0 0.234 
   Myocardial infarction 1.1 0.4 to 2.5 0.909 
   Unstable angina 2.7 1.1 to 6.8 0.035* 
Prior revascularisation 0.2 0.03 to 1.6 0.125 
Prior hypertension 1.7 0.7 to 4.2 0.263 
Reperfusion received 0.7 0.3 to 1.4 0.302 
Length of hospital stay (median) 1.1 1.03 to 1.1 <0.001‡ 
Depressed 2.8 1.4 to 5.7 0.005† 
*p<0.05, †p<0.01, ‡p<0.001 
 
 
 
 
Figure 1: Flowchart of patient participation 
 
 
 
 
 Figure 2: Survival (Kaplan-Meier) curves showing probability of survival by days 
for (a) depressed and non-depressed patients, (b) patients who completed the 
HADS-D, (c) patients who completed the BDI-FS 
 
 
 
